the ts 1 survivors did not contain detectable levels of anti-cvb3 ( m ) neutralizing antibody , but upon challenge with cvb3 ( m ) they produced antibody more rapidly and to higher titers than did normal cd-1 adolescents after primary inoculation with cvb3 ( m ) .
C0475463
neutralizing antibody
C0003241
antibody